Clinical Trial Results:
A phase III, multicenter, uncontrolled, open label study to demonstrate safety, tolerability and immunogenicity of the Chiron Behring preservative free inactivated split influenza vaccine using the strain composition 2005/2006
Summary
|
|
EudraCT number |
2005-000430-20 |
Trial protocol |
DE |
Global completion date |
02 Jun 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2019
|
First version publication date |
13 Feb 2019
|
Other versions |
|
Summary report(s) |
V44P9S |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.